ANDA Lull Begins: OGD Receives Four Applications In July
Executive Summary
A former FDA official suggests ANDA sponsors are waiting until the Office of Generic Drugs launches its formal review goals in October before filing applications.
You may also be interested in...
ANDA Submissions Drop To Start FY2021
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
ANDA Submissions Drop To Start FY 2021, Perhaps Forced Down By COVID-19
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
Generic Drug Application Submission Downturn Continued In June
Approvals also plummeted, but US FDA remains on a record-breaking pace.